논문KCI 등재
Denosumab, an effective osteoporosis treatment option for men
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
주제분류내과학
초록
.
Abstract
.
참고문헌 (12)
- Harvey NC, "Mind the(treatment)gap : a global perspective on current and future strategies for prevention of fragility fractures", Osteoporos Int, 28, pp.1507~1529 (2017)
- "Osteoporosis Fact Sheet 2019" (2019)[URL]
- Gennari L, "New and developing pharmacotherapy for osteoporosis in men", Expert Opin Pharmacother, 19, pp.253~264 (2018)
- Cummings SR, "Denosumab for prevention of fractures in postmenopausal women with osteoporosis", N Engl J Med, 361, pp.756~765 (2009)
- Chaiho Jeong, "The efficacy of denosumab in Korean male patients with osteoporosis", The Korean Journal of Internal Medicine, 37(5), pp.1011~1020 (2022), 대한내과학회[DOI]
- Farlay D, "Bone mineral and organic properties in postmenopausal women treated with denosumab for up to 10 years", J Bone Miner Res, 37, pp.856~864 (2022)
- 이유미, "Real-World Safety and Effectiveness of Denosumab in Patients with Osteoporosis: A Prospective, Observational Study in South Korea", Endocrinology and Metabolism, 37(3), pp.497~505 (2022), 대한내분비학회[DOI]
- Tanaka S, "Long-term safety and effectiveness of denosumab in Japanese patients with osteoporosis : 3-year post-marketing surveillance study", J Bone Miner Metab, 39, pp.463~473 (2021)
- Okubo N, "Relationship between bone mineral density and risk of vertebral fractures with denosumab treatment in japanese postmenopausal women and men with osteoporosis", Calcif Tissue Int, 107, pp.559~566 (2020)
- Orwoll E, "A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density", J Clin Endocrinol Metab, 97, pp.3161~3169 (2012)
- Kendler DL, "Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy", J Bone Miner Res, 25, pp.72~81 (2010)
- Miller PD, "Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates", J Clin Endocrinol Metab, 101, pp.3163~3170 (2016)
관련 논문AI추천
The efficacy of denosumab in Korean male patients with osteoporosis권혁상, 백기현, 송기호, 하정훈, Chaiho Jeong, Jinyoung Kim, Mee Kyoung Kim, Moo-Il Kang, Yejee Lim대한내과학회 · The Korean Journal of Internal Medicine2022 · 제37권 제5호Treatment of Osteoporosis: Unmet Needs and Emerging SolutionsBente Lomholt Langdahl, Jane Dahl Andersen대한골대사학회 · 대한골대사학회지2018 · 제25권 제3호Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension강무일, 고정민, 김인주, 민용기, 박일형, 오한진, 이일섭, 정동진, 정윤석, Antonio Nino, Barbara Kravitz, Brian Waterhouse, Lorraine A. Fitzpatrick연세대학교의과대학 · Yonsei Medical Journal2016 · 제57권 제4호The Effect of Denosumab on Bone Mass in Super Elderly Patients하정훈, Chaiho Jeong대한골대사학회 · 대한골대사학회지2020 · 제27권 제2호Up-to-Date Knowledge on Osteoporosis Treatment Selection in Postmenopausal WomenHee Jeung Lim, Hye Gyeong Jeong, Min Kyung Kim, Seul Ki Kim대한폐경학회 · 대한폐경학회지2022 · 제28권 제3호Effect of Romosozumab on Trabecular Bone Score Compared to Anti-Resorptive Agents in Postmenopausal Women with Osteoporosis강무일, 김진영, 백기현, 임예지, 정채호, 하정훈대한골대사학회 · 대한골대사학회지2021 · 제28권 제4호
이 간행물의 다른 논문 (24건)
Inflammatory bowel disease in Korea: epidemiology and pathophysiologyJung Won Lee, 은창수pp. 885-894Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-αJae Hee Cheon, Jihye Parkpp. 895-905Management of inflammatory bowel disease beyond tumor necrosis factor inhibitors: novel biologics and small-molecule drugsSoo-Young Na, You Sun Kimpp. 906-919Vaccination strategies for Korean patients with inflammatory bowel diseaseEun Soo Kim, Yoo Jin Leepp. 920-9302022 Consensus statement on the management of familial hypercholesterolemia in KoreaTask Force Team for Familial Hypercholesterolemia, Korean Society of Lipid and Atherosclerosis, 최성희, 이상학, 정인경, 이찬주, Minjae Yoon, Hyun-Jae Kang, Byung Jin Kimpp. 931-944